Prediction of patient-specific risk for fetal loss using maternal characteristics and first- and second-trimester maternal serum Down syndrome markers
β Scribed by Lorraine Dugoff; Howard S. Cuckle; John C. Hobbins; Fergal D. Malone; Michael A. Belfort; David A. Nyberg; Christine H. Comstock; George R. Saade; Keith A. Eddleman; Peer Dar; Sabrina D. Craigo; Ilan E. Timor-Tritsch; Steven R. Carr; Honor M. Wolfe; Mary E. D'Alton
- Book ID
- 113433878
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 130 KB
- Volume
- 199
- Category
- Article
- ISSN
- 1097-6868
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
It has been suggested that high levels of maternal serum prostate-specific (PSA) may be associated with fetal Down syndrome. We retrieved stored blood samples from 102 singleton Down syndrome pregnancies at 8-14 weeks' gestation and 99 at 15-22 weeks' gestation, together with samples from five unaff
The potential of the maternal serum concentration of schwangerschaftsprotein 1 (MSSP1) as a marker for Down syndrome (DS) pregnancies was evaluated in the fifth to the 20th gestational week using 156 DS pregnancies and 546 unaffected control pregnancies. In DS pregnancies, the median of the multiple